Liver computed tomographic perfusion in the assessment of microvascular invasion in patients with small hepatocellular carcinoma

Investigative Radiology

Volumn 50, Issue 4, 2015, Pages 188-194

  Wu, Dong ^a,b   Tan, Ming ^a,b   Zhou, Meiling ^a,b   Sun, Huichuan ^a,c   Ji, Yuan ^a   Chen, Lingli ^a   Chen, Gang ^a,b   Zeng, Mengsu ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Institute of Material Medical   (China)

^c Shanghai Cancer Center   (China)

Author keywords

Hepatocellular carcinoma; Microvascular invasion; Perfusion; X ray computed tomography

Indexed keywords

IOPAMIDOL;

ADULT; ARTICLE; CANCER PATIENT; CANCER SURGERY; CLINICAL ASSESSMENT; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER PERFUSION; LIVER RESECTION; LIVER SCINTISCANNING; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMALL HEPATOCELLULAR CARCINOMA; TUMOR INVASION; TUMOR VOLUME; COMPUTER ASSISTED TOMOGRAPHY; LIVER TUMOR; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; REPRODUCIBILITY; RETROSPECTIVE STUDY; VASCULARIZATION;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84925257991     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000098     Document Type: Article

References (47)

1. Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol. 2009;44(suppl 19):96-101.
2. Wong R, Frenette C. Updates in the management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y). 2011;7:16-24.
3. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236.
4. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191:389-394.
5. Ikai I, Arii S, Kijiro M, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 2004;101:796-802.
6. Shirabe K, Kajiyama K, Harimoto N, et al. Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion. World J Gastroenterol. 2009;15:2632-2637.
7. Sala M, Llovet JM, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carainoma. Hepatology. 2004;40:1352-1360.
8. Fuks D, Dokmak S, Paradis V, et al. Benefit of initial resection of HCC followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology. 2012;55:132-140.
9. Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intra-arterial injection of contrast medium. Am J Roentgenol. 1999;172:969-976.
10. Akihiro N, Kengo Y, Yoshiki A, et al. Radiologic delectability of minute portal venous invasion in hepatocellular carcinoma. Am J Roentgenol. 2008;190:81-87.
11. Pandharipande PV, Krinsky GA, Rusinek H, et al. Perfusion imaging of the liver: current challenges and future goals. Radiology. 2005;234:661-673.
12. Miles KA, Hayball M, Dixon AK. Colour perfusion imaging: a new application of computed tomography. Lancet. 1991;337:643-645.
13. Miles KA, Charnsangavej C, Lee FT, et al. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol. 2000;7:840-850.
14. Ippolito D, Sironi S, Pozzi M, et al. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization. Eur J Radiol. 2010;73:148-152.
15. Petralia G, Fazio N, Bonello L, et al. Perfusion computed tomography in patients with hepatocellular carcinoma treatedwith thalidomide: initial experience. J Comput Assist Tomogr. 2011;35:195-201.
16. Kanda T, Yoshikawa T, Ohno Y, et al. Perfusion measurement of the whole upper abdomen of patients with and without liver diseases: initial experience with 320-detector row CT. Eur J Radiol. 2012;81:2470-2475.
17. Chinese Society of Liver Cancer, Chinese Anti-Cancer Association Chinese Society of Clinical Oncology, Chinese Anti-Cancer AssociationLiver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association. Expert consensus on the norms of local ablation therapy for hepatocellular carcinoma [in Chinese]. Zhonghua Gan Zang Bing Za Zhi. 2011;19:257-259.
18. Stamm G, Nagel HD. CT-Expo - a novel program for dose evaluation in CT [in German]. Rofo. 2002;174:1570-1576.
19. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology. 1993;188:405-411.
20. Dugdale PE, Miles KA. Hepatic metastases: the value of quantitative assessment of contrast enhancement on computed tomography. Eur J Radiol. 1999;30:206-213.
21. Blomley M, Coulden R, Dawson P. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr. 1995;19:424-433.
22. Tsushima Y, Blomley JK, Kusano S, et al. The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage. Dig Dis Sci 1999;44:1632-1638.
23. Rodriguez-Peralvarez M, Luong TV, Andreana L, et al. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol. 2013;20:325-339.
24. Huang ZY, Liang BY, Xiong M, et al. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Ann Surg Oncol. 2012;19:2515-2525.
25. Chan SC, Fan ST, Chok KS, et al. Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion. Hepatol Int. 2011;6:646-656.
26. Kim BK, Han KH, Park YN, et al. Prediction ofmicrovascular invasion before curative resection of hepatocellular carcinoma. J Surg Oncol. 2008;97:246-252.
27. Kaibori M, Ishizaki M, Matsui K, et al. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J Surg Oncol. 2010;102:462-468.
28. Witjes CD, Willemssen FE, Verheij J, et al. Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2012;36:641-647.
29. Eguchi S, Takatsuki M, Hidaka M, et al. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg. 2010;34:1034-1038.
30. Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086-1092.
31. Sterling R, Wright E, Morgan T, et al. Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with chronic hepatitis C and advanced fibrosis with and without HCC. Hepatology. 2010;52(suppl 1):328A.
32. Faggioni L, Neri E, Bartolozzo C. CT perfusion of head and neck tumors: how we do it. Am J Roentgenol. 2010;194:62-69.
33. Kambadakone AR, Sahani DV. Body perfusion CT: technique, clinical applications, and advances. Radiol Clin North Am. 2009;47:161-178.
34. Spira D, Schulze M, Saulter A, et al. Volume perfusion-CT of the liver: insights and applications. Eur J Radiol. 2012;81:1471-1478.
35. Meijerink MR, Waesberghe JHTM, Weide L, et al. Total-liver-volume perfusion CTusing 3-D image fusion to improve detection and characterization of liver metastases. Eur Radiol. 2008;18:2345-2354.
36. Shankar JJ, Lum C. Whole brain CT perfusion on a 320-slice CT scanner. Indian J Radiol Imaging. 2011;21:209-214.
37. Chen C, Liu Q, Hao Q, et al. Study of 320-slice dynamic volume CT perfusion in different pathologic types of kidney tumor: preliminary results. PLoS One. 2014;9:e85522.
38. Goetti R, Leschka S, Desbiolles L, et al. Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases. Invest Radiol. 2010;45:419-426.
39. Goetti R, Reiner CS, Knuth A, et al. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound. Invest Radiol. 2012;47:18-24.
40. Morsbach F, Pfammatter T, Reiner CS, et al. Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases. Invest Radiol. 2013;48:787-794.
41. Wang X, Xue H-D, Jin Z-Y, et al. Quantitative hepatic CT perfusion measurement: comparison of Couinaud's hepatic segments with dual-source 128-slice CT. Eur J Radiol. 2013;82:220-226.
42. Haberland U, Klotz E, Abolmaali N. Performance assessment of dynamic spiral scan modes with variable pitch for quantitative perfusion computed tomography. Invest Radiol. 2010;45:378-386.
43. Tsushima Y, Fubasama S, Aoki J, et al. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol. 2004;11:215-223.
44. Fournier LS, Cuenod CA, de Bazelaire C, et al. Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent. Eur Radiol. 2004;14:2125-2133.
45. Van Beers BE, Leconte I, Materne R, et al. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. Am J Roentgenol. 2001;176:667-673.
46. Lu XY, Xi T, Lau WY, et al. Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior. J Cancer Res Clin Oncol. 2011;137:567-575.
47. Reiner CS, Goetti R, Eberli D, et al. CT perfusion of renal cell carcinoma: impact of volume coverage on quantitative analysis. Invest Radiol. 2012;47:33-40.